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Available online 21 February 2008The development of the peptide-based vectors for the intracellular delivery of biologically active
macromolecules has opened new prospects of their application in research and therapy. Earlier the
amphipathic cell-penetrating peptide (CPP) Pep-1was reported tomediate cellular uptake of proteins without
covalent binding to them. In this work we studied the ability of a series of membrane-active amphipathic
peptides, based on the gramicidin A sequence, to transport a model protein across the eukaryotic cell
membrane. Among them the positively charged Cys-containing peptide P10C demonstrated the most
effective β-galactosidase intracellular delivery. Besides, this peptide was shown to form noncovalent
associates with β-galactosidase as judged from electrophoresis and enzymatic activity assays. In addition, a
series of new gramicidin analogues were prepared and the effect of N-terminus modiﬁcation of gramicidin
on the protein transduction efﬁciency was studied.
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Amphipathic peptides1. Introduction
Impermeability of the cell membrane for hydrophilic molecules is
an important factor restricting the use of peptide- and protein-based
drugs. To resolve this problem, a number of approaches, e.g.
microinjection, electroporation, application of liposomal and viral
vectors, have been developed. A series of studies have demonstrated
that short fragments of several proteins named “protein transduction
domains” (PTDs) are responsible for the internalization of the proteins
[1–6], and since then the idea of creating peptide-based delivery
systems has attracted considerable interest. In particular, the Tat48–60
peptide (the fragment of the HIV-1 Tat protein) and Penetratin,
derived from the 60-amino acid residue homeodomain of the Droso-
phila Antennapedia transcription factor, should be mentioned [7].
Along with protein-derived PTDs, a number of chimeric and synthetic
peptides, called “cell-penetrating peptides” (CPPs) have been devel-
oped [7–11]. It was shown that these peptides can translocate a variety
of covalently linked cargo components, such as proteins [12,13],
peptides [14], oligonucleotides [15] and even nanoparticles [16] andtein transduction domain; NLS,
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lsevier B.V.liposomes [17], across membranes, which led to extensive use of CPPs
as delivery systems.
The requirement of covalent binding of a vector peptide to the
cargo restricts considerably the use of peptide-based delivery systems.
Recently a peptide (named Pep-1) which forms noncovalent com-
plexes with proteins and transfers them across membranes [18], has
been described. This peptide is composed of two main fragments: the
relatively hydrophobic sequence containing 5 Trp residues (KEW-
WETWWTEW) and the Lys-rich motif (KKKRKV) derived from the
nuclear localization sequence of simian virus 40 large T antigen; two
fragments are linked by a short spacer (SQP). C- and N-terminus of the
peptide are capped with cysteamine and acetyl groups, respectively.
Another cell-penetrating peptide, YTA2, developed by Lindgren et al.
has also been shown to deliver proteins into cells without chemical
coupling between the peptide and a cargo protein [19]. The above
mentioned CPPs are built according to similar rules and have amphi-
pathic structures.
Antimicrobial peptides represent another class of amphipathic
peptides. The differentiation of these two classes of peptides is rather
formal and the overlap between the structure and the mode of action
of CPPs and antimicrobial peptides has been noted [20,21]. For
example, antimicrobial peptides in several cases were shown to enter
eukaryotic cells [22]. Moreover, the cell-penetrating peptide Pep-1 is
readily transformed to an antibiotic by Glu→Lys substitution in the
hydrophobic domain [23]. On the other hand, such CPPs as pVec and
TP10 display distinct antimicrobial activity [24].
In preceding communications, we described synthesis and ion
channel activity of a series of amphipathic peptides, based on the
gramicidin A sequence [25,26]. In the present work we investigated
the ability of such peptides to deliver proteins into eukaryotic cells
using β-galactosidase as a cargo. The hydrophobic membrane-active
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afﬁnity to the cell membrane. Besides, we expected the gramicidin motif
with its 4 Trp residues to provide the formation of peptide–protein
complexes via hydrophobic interactions, similarly to the Trp-rich domain
of Pep-1 responsible for binding to the protein cargo [27]. The basic
nuclear localization sequence derived from the SV-40 virus (KKKRKV)
that was attached through a short spacer (GSG) to the C-terminus of
gramicidin A, improved its solubility in aqueous solutions and was
expected to induce cellular uptake. Furthermore, new analogues
containing NLS at the N-terminus and those with the free N-terminus
were prepared and studied.
2. Materials and methods
Rink amide resin and Trityl chloride resin for peptide synthesis was purchased from
PepChem (Tubingen, Germany), Fmoc-protected amino acids were from Novabiochem
(Bad Soden, Germany), standard chemicals for peptide chemistry were obtained from
Fluka (Deisenhofen, Germany) and Chimmed (Moscow, Russia). Solvents were pure
analytical grade. β-Galactosidase, o-nitrophenil-β-D-galactoside and (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) (MTT) were obtained from
Sigma Aldrich (Steinheim, Germany), 5-Bromo-4-chloro-3-indolyl-β-D-galactoside
(X-Gal) was from Bethesda Research Laboratories (Gaithersburg, MD). glutaralde-
hyde, 2-mercaptoethanol and Triton X-100 were purchased from Fluka (Deisenhofen,
Germany).
Dulbecco's Modiﬁed Eagle's Medium (DMEM), L-glutamine, fetal bovine serum
(FBS), trypsin–EDTA solution, streptomycin and penicillin, were purchased from Gibco
Invitrogen Corp. (Carlsbad, CA).
2.1. Peptide synthesis
The synthetic peptides used in this study are listed in Table 1. Synthesis of the
peptides P10C, N1C, P5C, P4C has been described in our previous reports [25,26].
Synthesis of new peptides was carried out by the solid phase method on Rink amide
resin [4(2′,4′-Dimethoxyphenyl-Fmoc-aminomethyl)-phenoxy resin] following the
standard Fmoc chemistry procedure by using HOBt/DIC/N,N-dimethylformamide
coupling reactions. Pep-1 was synthesized by means of standard solid phase Fmoc
chemistry on trityl chloride resin, preloaded with Fmoc-cysteamine. N-terminal
formylation (P4C) and N-terminal acetylation (Pep-1, P10C, P5C, N1C) of peptides
were carried out using 4-nitrophenyl formate and acetic anhydride respectively, in the
presence of N-ethyldiisopropylamine. The peptide resins were treated with triﬂuor-
oacetic acid–ethandithiol–water (94:3:3) for 2.5h. Peptides were puriﬁed by pre-
parative HPLC on a C4 columnwith ethanol gradient in 0.1% triﬂuoroacetic acid inwater
and characterized by analytical HPLC and matrix-assisted laser desorption ionization
time-of-ﬂight (MALDI-TOF) analysis. The overall yields starting from the aminoacid–
resin conjugates were 9–25%.
2.2. Cells and cell cultures
Adherent HeLa, L-929 and NIH-3T3 cells were routinely cultured as exponention-
ally growing subconﬂuent monolayers in 25-cm2 cultural ﬂasks in Dulbecco's Modiﬁed
Eagle's Medium supplemented with 10% (v/v) fetal calf serum, 2 mM L-glutamine,
100 U/ml penicillin, and 100 U/ml streptomycin (growth medium) in a humidiﬁed 5%
CO2 (37 °C) incubator. Cells were split in 1/4 dilution every 3–4 days, after they reached
conﬂuency. Jurkat lymphoid and Sp2/0 cells were cultured in suspension in RPMI 1640
medium supplemented with 10% (v/v) fetal calf serum and 2 mM glutamine, 100 U/ml
penicillin, and 100 g/ml streptomycin in a humidiﬁed 5% CO2 (37 °C) incubator.Table 1
Amino acid sequences and molecular masses of the peptides examined in this study
Peptide Sequence Molecular mass (Da)
Calculated Measured from
mass-spectra
P10C Ac-V G A l A v V v W l W l W l W
βAGSGPKKKRKVC-amide
3091.8 3092.0
P4C Form-V G A l A v V v W l W l W l W
βAGSGPKKKRKVC-amide
3077.8 3076.8
P5C Ac-V G A l A v V v W l W l W l W
βAGSGPKKKRKVG-amide
3046.7 3046.5
N1C Ac-V GA l Av V vW lW lW lW βAGSGEEEESQS 2843.9 2843.4
P11C V G A l A v V v W l W l W l W
βAGSGPKKKRKVC-amide
3049.8 3050.5
P1N CPKKKRKVGSGV G A l A v V vW lW l W l W βA 3048.8 3050.6
P3N CVKRKKKPGSGV G A l A v V vW lW l W l W βA 3048.8 3049.8
D-amino acids are printed in the lower-case letters.
Symbol βA denotes β-alanine residue.2.3. Cellular uptake of P10C/β–Gal complexes
Peptide/β-Gal complexes were formed by titration of 0.25 μM protein with the
peptide in PBS with subsequent incubation for 30 min at ambient temperature. Cells
were washed with DMEM and treated with the preformed protein/peptide complexes
solutions (the molar ratio from 7 to 600 and from 1 to 1000 for Pep-1 and P10C,
respectively) diluted with DMEM. The amount of internalized β-Gal was determined by
measuring its enzymatic activity using two substrates. Before the X-Gal staining
procedure, cells were washed thoroughly with phosphate buffer and ﬁxed with 0.25%
glutaraldehyde solution. In the case of oNPG staining, in order to remove the protein
that could be associated with the outer membrane, after the washing step cells were
treated with trypsin–EDTA solution for 10min as described [28], lysedwith 0.2% Triton-
40 μM mercaptoethanol solution, and oNPG solution (4 mg/ml) was added. The
internalized protein was detected by the OD measurement at 405 nm.
2.4. Cytotoxicity assay
Cell viability was determined by the colorimetric assay with 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Brieﬂy, HeLa cells grown in 96-well
plates to 75% conﬂuency were incubated with 0.76–48 μM P10C or P4C in 30 μl DMEM
for 2 h, then peptide solutions were aspirated and 10% serumwas added. After 24 h 30 μl
of MTT (5 mg/mL) was added to each well. The product (MTT formazan) was solubilized
in dimethyl sulfoxide (DMSO) after 2 h, and cytotoxicity was evaluated by colorimetric
assay at 540 nm and a reference wavelength of 620 nm as described [29] using Titertek
Multiscan (Labsytems, Finland).
2.5. Polyacrylamide gel electrophoresis (PAGE)
Non-denaturing PAGE was used for the protein/peptide complex formation
analysis. It was performed by incubating 5.2 μM β-Gal with increasing amounts of
P10C for 30 min at ambient temperature in a ﬁnal volume of 10 μl, made up with
0.125 М Tris–HCl buffer (рН 7.5) containing 1% (v/v) of glycerol. Samples were applied
onto the gel composed of 5% stacking gel and 10% resolving gel, and run under native
conditions, in 25 mM Tris, 19.2 mM glycine, pH 8.3 at 20 mA for 2 h at 4 °C. Gels were
ﬁxed in 50% ethanol solution containing 20% of acetic acid and stained in 0.12%
Coomasie brilliant blue R, 45% methanol, 10% acetic acid for 20 min and destained in
45% methanol, 10% acetic acid. The gels were scanned and the amount of free protein
was estimated by gel image analysis based on measuring of total protein bands
intensities. The analysis was performed using home-made software.
2.6. Enzymatic assay of β-galactosidase
Enzymatic activity of β-Gal was estimated by colorimetric assay, detecting at
405 nm the product of the hydrolysis of o-nitrophenil-β-D-galactoside (oNPG). The
peptide solution was added at peptide/protein ratios from 1 to 30,000 to the enzyme
dissolved in PBS (pH 7.4) and incubated for 40 min at 37 °C. The substrate solution was
added at nonlimiting concentrations in PBS (pH 7.4) and the assay was followed by the
optical density measurement.
3. Results
3.1. Intracellular delivery of β-Galactosidase induced by gramicidin A
derivatives
To examine the ability of the amphipathic gramicidin analogues
described in our previous reports (P4C, P5C, P10C, N1C) and the new
gramicidin derivatives (P11C, P3N) to translocate proteins across the
cell membrane, the reporter protein β-galactosidasewas used because
of its convenient detection via enzymatic activity. The β-Gal uptake
induced by gramicidin analogues was studied in human carcinoma
cell line (HeLa) and the cell-transducing activity of all the derivatives
was compared. Complexes of the peptides with the protein were
formed as described above. Two hours proved to be the optimal time
of incubation with HeLa cells (data not shown) as measured by two
different staining procedures. X-Gal substrate is degraded by β-Gal
giving rise to a blue-colored water-insoluble product which is
observed in the cells directly (Fig. 1A). To estimate the efﬁciency of
cellular uptake of β-Gal, we used oNPG staining (Fig. 1B). In order to
exclude the contribution of the protein associated with the external
membrane, cells were treated with 0.25% trypsin solution before
oNPG staining [28,30].
It was found that the analogue N1C modiﬁed with a negatively
charged sequence showed no cell-transducing activity (Fig. 1A),
whereas analogues containing the basic motif (P5C, P10C, P11C, P1N,
P3N) transported the protein across the membrane (Fig. 1B, C, D).
Fig. 1. Intracellular delivery of β-Gal induced by amphipathic gramicidin A derivatives. HeLa cells were grown under standard conditions and then incubated for 2 h at 37 °C with
complexes preformed by mixing of β-Gal solution (0.03 mg/ml) with different concentrations of peptides, varying the peptide concentration from 0.082 to 10.5 μM. Then cells were
extensively washed with PBS before staining and β-Gal was detected by enzymatic activity using two different substrates. (A) Light micrographs of the X-Gal stained (blue colored)
cells showing the β-Gal delivery mediated by P10C, and N1C (peptide concentration 2.65 μM). Before staining cells were ﬁxedwith 0,25% glutaraldehyde. (B) Comparison of the β-Gal
internalization by means of P10C (black curve) and its analogue P5C (grey curve) containing Gly residue instead of Cys at the C-terminus. (C) Comparison of transduction activity of
acetylated (black curve) and free N-terminal (grey curve) analogues. (D) Illustration of the identical transduction activity of P10C (black squares) and its analogues, containing normal
(white circles) or reversed (grey triangles) NLS motif at the N-terminus. oNPG substrate (4 mg/ml) was used for quantitative estimation of the inserted protein. Before lysis and
staining procedure cells were treated with trypsin to hydrolyze protein associated with the external cell membrane. Optical density was measured at 405 nm after 30 min of
incubation with substrate solution. Data are presented as means±S.D., based on triplicates of at least two independent experiments.
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active than P5C. For example, no protein transductionwas observed at
a concentration of 0.8 µM in the case of P5C, whereas P10C delivered
β-Gal to the cells under these conditions. We explain the enhanced
transduction efﬁciency of P10C by oxidative dimerization of the
peptide which leads to more efﬁcient surface coverage of the protein.
Dimer formation after 12 h of storage was conﬁrmed by HPLC analysis
(data not shown).
It is known that ion channel formation by gramicidin A is critically
dependent on the modiﬁcations of the amino terminus of the peptide
[32,35–37]. To examine the effect of the N-terminus modiﬁcation on
the protein transduction process, we synthesized and studied new
gramicidin derivatives, the P11C containing free N-terminus and twoFig. 2. Р10С-mediated delivery of β-Gal. (A) Transmission images of the cells, stained with
incubated with protein/peptide complexes mixture for 2 h, washed thoroughly with PBS and
curve) and Pep-1 (grey curve). Protein/peptide complexes were formed by adding the P10C o
7 to 600 for P10C and Pep-1, respectively. Extensive washing and trypsin treatment precededderivatives with the positively chargedmotif shifted from the C- to the
N-terminus (P1N and P3N). Fig. 1C and d demonstrate that both
modiﬁcations did not affect the transduction activity of P10C. The
same transduction activity was observed with the analogue contain-
ing the inversed NLS at the N-terminus (Fig. 1D). It is concluded that
amphipathicity itself rather than the relative position of charged and
hydrophobic moieties is the factor determining the ability to transfer
protein across the membrane barrier. These data also indicate that no
speciﬁc receptor binding is involved in protein transport.
Thus it can be concluded that the gramicidin sequence modiﬁed
with the positively charged motif is required for β-Gal intracellular
delivery. For further detailed study the P10C analogue was chosen as
a representative sample. P10C-mediated β-Gal internalization wasX-Gal, demonstrating P10C/β-Gal complexes uptake in different cell lines. Cells were
stained with X-Gal solution. (B) Comparison of β-Gal delivery mediated by P10C (black
r Pep-1 solution to β-Gal at a peptide/protein molar ratio varying from 1 to 1000 and from
staining procedure. Internalized protein was detected by the OD measuring at 405 nm.
Fig. 3. Cytotoxic effect of P10C and inﬂuence of Ac Form replacement on peptide cytotoxicity. HeLa cells were incubated with increasing concentrations of P10C or P4C at 37 °C for 2 h.
Peptide solutions were aspirated and cells were overlaidwith 10% serummedium. After 12 h of incubation, 30 μl of MTT solution (5mg/mL) was added to eachwell. The product (MTT
formazan) was solubilized in dimethyl sulfoxide (DMSO) after 2 h, and cytotoxicity was evaluated by colorimetric assay at 540 nm. Data are shown as means±S.D., based on
quadruplates of at least two independent experiments. (А) Comparison of the cytotoxic concentration (grey bars) and optimal working concentration (black curve) of P10C. (В) P10C
(black curve) and P4C (grey curve) cytotoxic effects.
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3T3, COS-1, 293, CHO, L-929, Jurkat, Sp2/0). Fig. 2A showsmicrographs
of several cell lines demonstrating similar ability of P10C to deliver
β-Gal in various cell types.
To compare P10C with a vector described earlier (Pep-1),
complexes of β-Gal/Pep-1 were prepared as described in [18]. The
efﬁcient protein transduction was observed at the peptide/protein
ratio of 400:1 (M/M) with Pep-1, in agreement with the data
published earlier [31], and at the ratio of 50:1 with P10C (Fig. 2B).
3.2. Cytotoxicity
To check the effect of P10C on cells viability, we used the MTT assay
which reﬂects the activity of a mitochondrial enzyme, succinate
dehydrogenase, that is active in live cells only [29]. According to MTT
assay results with HeLa cells, P10C exhibited no toxicity at concentrations
up to 5.5 μM, while the efﬁcient transduction was observed with thisFig. 4. Protein/P10C complexes formation analysis. (A) Complex formation analysis. by polya
were formed by mixing 5.2 μM β-Gal solution with P10C solution at various molar ratios (fro
were loaded onto disc–polyacrylamide gel and run as described in Materials andmethods. Ge
20 min and destained in 45% methanol, 10% acetic acid. (B) Enzymatic activity assay of β-gala
the enzyme dissolved in PBS (pH 7.4) and incubated for 40 min at 37 °C. The substrate soluti
measured at 405 nm.peptide in the range of 0.3–3 μM (Fig. 3A). The formylated analogue P4C
was toxic at a concentration as low as 0.2 μM (Fig. 3B), the effect appar-
ently being related to the increase in channel-forming activity [32,33].
3.3. Formation of protein–peptide complexes
Non-denaturing polyacrylamide gel electrophoresis described in
[34] for proteins and protein–protein complexes was used here to
prove the protein–peptide interaction. As expected, P10C interacted
with β-galactosidase and the noncovalent complexes formed as a
result of this interaction did not enter the gel (Fig 4A). With increasing
P10C/protein ratio from1 to 40, the amount of the free protein decreased
and at the ratio of 50 the band corresponding to β-galactosidase was
undetectable and hence all the protein was associated with the peptide
(Fig. 4A).
The enzymatic activity of β-Gal mixed with various amounts of
P10C remained comparable to that of the free protein up to the ratio ofcrylamide gel electrophoresis at non-denaturing conditions. Protein/peptide complexes
m 1:1 to 1:70) in 0.125М Tris–HCl buffer (рН 7.5). After 30 min of incubation, samples
ls were stained in 0.12% Coomasie brilliant blue G-250, 45%methanol, 10% acetic acid for
ctosidase. The peptide solution was added at peptide/protein ratios from 1 to 30,000 to
on was added at nonlimiting concentrations in PBS (pH 7.4) and the optical density was
2030 T.B. Stoilova et al. / Biochimica et Biophysica Acta 1778 (2008) 2026–2031150 (Fig. 4B). The subsequent increase in the ratio resulted in the drop
of the enzymatic activity that was particularly notable starting from
the ratio of 300. Thus, high concentrations of P10C led to suppression
of β-Gal activity.
These results allowed us to explain the pattern of the dose
dependence of the transduction efﬁciency presented in Fig. 2B (black
curve). A steep rise of the transduction efﬁciency with increasing the
peptide/protein ratio up to the value of 70 was apparently related to
stimulation of the formation of P10C–β-Gal complexes as shown in
Fig. 4A. Adecrease in theefﬁciencyofβ-Gal uptake observed at the ratios
over 70 could be attributed to partial inhibition of the enzymatic activity
that was observed in this range of peptide concentrations (Fig. 4B).
4. Discussion
In this work we studied transduction of β-galactosidase across a
cell membrane induced by a series of peptides containing the
hydrophobic gramicidin A sequence modiﬁed by the Lys-rich motif.
We believed that along with the ability to insert into the membrane,
the gramicidin A sequence would be responsible for the formation of
complexes with proteins via hydrophobic interactions, whereas the
positively charged domain would improve water solubility of the
peptide and the intracellular transport of the protein–peptide
complexes. The present study demonstrated the effective intracellular
β-Gal delivery mediated by a series of the positively charged Cys-
containing gramicidin derivatives which were more efﬁcient than the
earlier designed vector Pep-1.
The crucial role of a basic domain in the protein delivery was
revealed earlier for various peptides [7,38]. In our work we have
shown that only the positively chargedmotif provides gramicidinwith
the ability to transport β-Gal. Most likely, electrostatic attraction
enhances the interaction between the peptide and the membrane
surface, which induces initial accumulation of peptide–protein
complexes on the membrane with subsequent insertion of the
hydrophobic sequence of the peptide into it. This hypothesis is in
agreement with previous studies pointing to electrostatic associa-
tion between negatively charged lipids and a basic domain as the
ﬁrst step of peptide–membrane interaction for both the antimicro-
bial peptide melittin and the cell-penetrating peptides penetratin
and Pep-1 [27,39,40]. Besides, basic residues could participate in
formation of protein–peptide complexes via electrostatic interac-
tions. At the same time, oligolysine (KKKKKKKKC) alone did not
induce protein internalization into cells under similar conditions
(data not shown).
The observed difference in effective concentrations of P10C and
P5C could result from oxidation of SH-groups leading to peptide
dimerization that promoted better covering of the protein surface
with the peptide. Besides, the dimer formation can improve the
interaction of the preformed protein/peptide complexes with the cell
membrane so that one of the monomers comprising the dimer is
associated with the protein whereas the other one interacts with the
lipid bilayer. Actually Weller et al. [27] reported the increased
membrane afﬁnity of cysteamine containing Pep-1 along with
improvement of protein transduction.
Earlier formation of large transmembrane pores was proposed as
the mechanism of the protein delivery mediated by two amphipathic
peptides (MPG and Pep-1) [11]. However, more recent data have
shown that pore formation is not involved in Pep-1-induced protein
transduction [41,31] and a physical mechanism governed by electro-
static peptide–membrane interaction was suggested for the Pep-1/β-
Gal complexes internalization [31].
Our previous experiments on artiﬁcial membrane systems have
demonstrated the ability of the positively charged amphipathic
analogues of gramicidin A to form unselective pores in the lipid
bilayer without causing membrane destabilization [26]. Moreover, it
was noted that the presence of H2O2 enhanced the unselective poreforming induced by Cys-containing analogues, which could be
explained by the increase in the local concentration of the peptide
as a result of cross-linking of two neighboring molecules [25]. In the
present study the enhancement of the protein transduction mediated
by Cys-containing derivatives in the presence of H2O2 was demon-
strated as well. Taking into account these data, the passive protein
translocation mechanism seems possible. However, the energy-
dependent translocation pathway such as endocytosis which is
considered to be the most probable mechanism of peptide cellular
uptake [9], cannot be excluded and additional experiments are needed
to conﬁrm the hypothesis of the passive mechanism of the P10C-
mediated β-Gal translocation.
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